Ligand Pharmaceuticals Incorporated
USD232.76
+2.98 (+1.30%)
CEO
Todd C. Davis
IPO Date
1992-11-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$229.43
Prev. Close
$229.78
Day Low
$227.76
Day High
$233.99
52W Low
$101.67
52W High
$247.38
Market Cap
$4.66B
Volume
0.18M
| 972 |
| $52.84 |
| 28 May 2026 | Espinoza Octavio | Chief Financial Officer | M-Exempt | Disposed | 972 | $52.84 |
| 28 May 2026 | Espinoza Octavio | Chief Financial Officer | M-Exempt | Disposed | 764 | $63.62 |
| 14 May 2026 | KOZARICH JOHN W | director | S-Sale | Disposed | 80 | $227.37 |
| 14 May 2026 | KOZARICH JOHN W | director | S-Sale | Disposed | 1 | $229.87 |
| 14 May 2026 | KOZARICH JOHN W | director | S-Sale | Disposed | 165 | $231.87 |
| 14 May 2026 | KOZARICH JOHN W | director | S-Sale | Disposed | 105 | $232.57 |
| 14 May 2026 | KOZARICH JOHN W | director | S-Sale | Disposed | 116 | $234.09 |
| 14 May 2026 | KOZARICH JOHN W | director | M-Exempt | Acquired | 459 | $69.51 |
| $1,001 - $15,000 |
| 13 Feb 2026 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 13 Feb 2026 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 13 Feb 2026 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 3 Dec 2020 | Katherine M. Clark | Katherine M. Clark | Sale (Full) | $1,001 - $15,000 |
| 29 May 2020 | Katherine M. Clark | Katherine M. Clark | Purchase | $1,001 - $15,000 |
| 29 May 2020 | Katherine M. Clark | Katherine M. Clark | Purchase | $1,001 - $15,000 |